Evidence map›Paper›PMID 39468329›Full record

ArticleMolecular systems biology2024

Deep quantification of substrate turnover defines protease subsite cooperativity.

Rajani Kanth Gudipati, Dimos Gaidatzis, Jan Seebacher, Sandra Muehlhaeusser, Georg Kempf, Simone Cavadini, Daniel Hess, Charlotte Soneson, Helge Großhans

Abstract read
In one paragraph

Article in Molecular systems biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rajani Kanth Gudipati *Friedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland.ORCID http://orcid.org/0000-0002-7364-9279
Dimos Gaidatzis *Friedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland.
Jan SeebacherFriedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland.ORCID http://orcid.org/0000-0002-7858-2720
Sandra MuehlhaeusserFriedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland.
Georg KempfFriedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland.ORCID http://orcid.org/0000-0002-0228-6730
Simone CavadiniFriedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland.
Daniel HessFriedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland.ORCID http://orcid.org/0000-0002-1642-5404
Charlotte SonesonFriedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland.ORCID http://orcid.org/0000-0003-3833-2169
Helge GroßhansFriedrich Miescher Institute for Biomedical Research, Fabrikstrasse 24, Basel, 4056, Switzerland. helge.grosshans@fmi.ch.ORCID http://orcid.org/0000-0002-8169-6905

Funding

National Science Center Poland (NCN) OPUS 2022/45/B/NZ2/02183National Science Center Poland (NCN) SONATA BIS 2021/42/E/NZ1/00336
6 · The paper itself

Abstract

Substrate specificity determines protease functions in physiology and in clinical and biotechnological applications, yet quantitative cleavage information is often unavailable, biased, or limited to a small number of events. Here, we develop qPISA (quantitative Protease specificity Inference from Substrate Analysis) to study Dipeptidyl Peptidase Four (DPP4), a key regulator of blood glucose levels. We use mass spectrometry to quantify >40,000 peptides from a complex, commercially available peptide mixture. By analyzing changes in substrate levels quantitatively instead of focusing on qualitative product identification through a binary classifier, we can reveal cooperative interactions within DPP4's active pocket and derive a sequence motif that predicts activity quantitatively. qPISA distinguishes DPP4 from the related C. elegans DPF-3 (a DPP8/9-orthologue), and we relate the differences to the structural features of the two enzymes. We demonstrate that qPISA can direct protein engineering efforts like the stabilization of GLP-1, a key DPP4 substrate used in the treatment of diabetes and obesity. Thus, qPISA offers a versatile approach for profiling protease and especially exopeptidase specificity, facilitating insight into enzyme mechanisms and biotechnological and clinical applications.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsDipeptidyl Peptidase 4Glucagon-Like Peptide 1AnimalsCatalytic DomainHumansMass SpectrometryPeptidesProtein EngineeringSubstrate SpecificityCaenorhabditis elegans ProteinsDipeptidyl Peptidase 4DPP4 protein, humanGlucagon-Like Peptide 1PeptidesCryo-EMDPP-IV Family ProteasesPeptide TurnoverProtein EngineeringQuantitative Modeling

Identifiers

PMID39468329
PMCPMC11612144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.